• 동의생리병리학회지
• /
• 제16권4호
• /
• pp.756-763
• /
• 2002

We have previously demonstrated that repeated injections of nicotine produced an increase in locomotor activity, dopamine(DA), release and c-Fos expression in the nucleus accumbens, one of the major projection areas of the central DA system. Acupuncture as a therapeutic intervention is widely used for the treatment of many functional disorders such as substance abuse and mental dysfunction. And many studies have shown that Coptidis Rhizoma has a suppressive effect on the central nervous system (CNS) and can affect the neurotransmitter systems in the CNS. In order to investigate whether acupuncture and Coptidis Rhizoma have an influence on nicotine-induced reinforcing and behavioral effects, we examined the effect of zusanli(ST36) and Coptidis Rhizoma on repeated nicotine-induced locomotor activity, and zusanli(ST36) on c-Fos expression as an important maker of postsynaptic neuronal activity in nucleus accumbens. Male SD rats received Coptidis Rhizoma (100mg/kg, p.o.) 30 min before injections of nicotine (0.4 mg/kg, s.c.) for 7 days. Rats were followed withdrawal for 3 days and one challenge for 1 day. Systemic challenge with nicotine produced a much larger increase in locomotor activity. Pretreatment with acupuncture at zusanli(ST36, 100Hz) and Coptidis Rhizoma decreased in nicotine-induced locomotor activity. These results demonstrated that reduction in locomotor activity by acupuncture at zusanli(ST36, 100Hz) and Coptidis Rhizoma may be mediated by reduction of dopamine release. Our results suggest that acupuncture at zusanli(ST36, 100Hz) and Coptidis Rhizoma may have therapeutic effect on nicotine addiction.

• 정신신체의학
• /
• 제7권2호
• /
• pp.256-262
• /
• 1999

만성 통증은 신체적, 심리적, 사회환경적 요인들이 복합적으로 작용한 결과로서 나타나기 때문에 생물정신사회적 관점에서 접근해야 하며 치료는 다각적이고 포괄적인 체제하에서 상호 긴밀한 협력을 필요로 한다. 치료의 목표는 즉각적인 통증의 해소보다는 재활에 초점을 맞추어 환자의 활동과 기능이 증진됨에 따라 부수적으로 통증이 완화될 수 있도록 해야 할 것이다. 정신과적 영역에서 만성 통증의 치료는 정신의학적 평가로부터 시작하는데 여기에는 스트레스와 연관된 통증의 정신생리적 기전과 이상 질병행동과 관련된 조작적 조건화 기전, 그리고 증상으로서 통증을 동반하거나 만성 통증에 의해서 유발되는 정신과적 질환들에 대한 평가가 포함된다. 정신과적 치료를 약물치료와 심리적 치료로 나눌 때 약물치료에는 마약성 진통제, 비스테로이드성 소염제, 향정신성약물, 항경련제 들이 포함되는데 그 중에서도 항우울제가 가장 중요한 역할을 한다. 심리적 치료로는 역동적 정신치료와 행동치료적 방법들이 있고 행동치료적 접근법에는 자가조절기법과 조작적 조건화기법 등이 포함되는데, 환자가 갖는 대인관계의 어려움, 신체적 손상, 이상 질병행동 등을 고려하여 적절한 방법을 적용하게 된다.

• Biomolecules & Therapeutics
• /
• 제20권1호
• /
• pp.1-18
• /
• 2012

Schizophrenia is a devastating psychiatric illness that afflicts 1% of the population worldwide, resulting in substantial impact to patients, their families, and health care delivery systems. For many years, schizophrenia has been felt to be associated with dysregulated dopaminergic neurotransmission as a key feature of the pathophysiology of the illness. Although numerous studies point to dopaminergic abnormalities in schizophrenia, dopamine dysfunction cannot completely account for all of the symptoms seen in schizophrenia, and dopamine-based treatments are often inadequate and can be associated with serious side effects. More recently, converging lines of evidence have suggested that there are abnormalities of glutamate transmission in schizophrenia. Glutamatergic neurotransmission involves numerous molecules that facilitate glutamate release, receptor activation, glutamate reuptake, and other synaptic activities. Evidence for glutamatergic abnormalities in schizophrenia primarily has implicated the NMDA and AMPA subtypes of the glutamate receptor. The expression of these receptors and other molecules associated with glutamate neurotransmission has been systematically studied in the brain in schizophrenia. These studies have generally revealed region- and molecule-specifi c changes in glutamate receptor transcript and protein expression in this illness. Given that glutamatergic neurotransmission has been implicated in the pathophysiology of schizophrenia, recent drug development efforts have targeted the glutamate system. Much effort to date has focused on modulation of the NMDA receptor, although more recently other glutamate receptors and transporters have been the targets of drug development. These efforts have been promising thus far, and ongoing efforts to develop additional drugs that modulate glutamatergic neurotransmission are underway that may hold the potential for novel classes of more effective treatments for this serious psychiatric illness.

• 한국산학기술학회논문지
• /
• 제16권1호
• /
• pp.462-470
• /
• 2015

본 연구는 사회경제적 차이가 아동의 뇌기능과 문제행동증후에 미치는 영향에 대해서 살펴보았다. 장애, 질병 또는 인지기능에 문제가 없는 저소득층(LIC) 아동 30명, 중산층(MC)아동 30명을 대상으로 2013년 1월부터 4월까지 뇌기능 분석과 K-CBCL을 이용한 아동문제행증후의 데이터를 측정 분석하였다. 연구 결과는 첫째, LIC아동은 MC아동보다 세타파(${\Theta}$), SMR파의 비율과 델타파(${\delta}$), 고베타파(${\beta}h$), 알파파(${\alpha}$):저베타(${\beta}l$)의 비율이 유의미하게 높게 나타났고, MC아동은 LIC아동보다 자기조절지수 주의지수 정서지수 항스트레스지수 브레인 지수의 값에서 더 유의미하게 높다는 것을 보여주었다. 둘째, 아동문제행동증후는신체증상, 우울/불안, 사회적 미성숙, 사고의 문제, 주의집중문제, 공격성, 내재화, 외현화, 총 문제행동, 정서불안정에 있어서 LIC아동이 MC아동에 비해서 더 유의미하게 높았고, MC아동은 사회성, 학업수행능력, 총 사회능력에서 LIC아동보다 유의미하게 높았다. 결론적으로, LIC아동과 MC아동의 사회경제적 차이가 상기 뇌기능과 문제행동증후에 영향을 미치는 것으로 밝혀졌다.

• 수면정신생리
• /
• 제5권2호
• /
• pp.134-154
• /
• 1998

This paper first reviewed the definition, criteria, and neurological theories concerning the etiology of AD/HD, and the empirical studies dealing with the comorbidity of AD/HD with other psychiatric disorders. Secondly, results of studies using various neuropsychological tests for assessing the cognitive and behavioral problems in AD/HD children were examined, which suggest the possibility that dysfunction may exist in neural pathways involving many areas of the brain in AD/HD. However, because most of neuropsychological test used in Korea for ADHD children had been developed abroad, further study involving AD/HD, normal control, and other psychiatric control groups is needed to obtain developmental norms for interpreting the results, and to make more accurate diagnosis, and to clarify comorbidity of AD/HD with other disorders.

• Journal of mucopolysaccharidosis and rare diseases
• /
• 제5권1호
• /
• pp.39-41
• /
• 2021

Prader-Willi syndrome (PWS) is a rare genetic neurodevelopmental disorder of hyperphagia leading to severe obesity, intellectual deficits, compulsivity, and other behavioral problems. PWS is caused by the inactivation of contiguous genes on chromosome 15q11-q13, which complicates the development of targeted, effective therapeutics. Various preclinical studies have been conducted by developing mouse models that exhibit phenotypes similar to PWS. Oxytocin deficiency in PWS is associated with hyperphagia with impaired satiety and, food-seeking and behavior disorders. Here, we summarize the oxytocin study of ingestion behavior tested in the PWS mouse model and published data from clinical trials that have evaluated treatment effectiveness on ingestion behavior and social dysfunction in patients with PWS.

• 셀메드
• /
• 제13권14호
• /
• pp.14.1-14.9
• /
• 2023

Administration of Scopolamine can be considered a psychopharmacological model of Alzheimer's disease (AD). We made an animal model of Alzheimer's disease (AD) by administering Scopolamine to Blab/c mice. In this study, we investigated the effects of Resplex Alpha on memory impairment and cognitive function in mice in a mouse animal model of Scopolamine-induced memory impairment. Through Y-mazed and passive avoidance behavioral assays, we observed that Resplex Alpha recovered Scopolamine-induced short-term memory and cognitive functions. The results of our study imply that Resplex Alpha may be beneficial in the prevention of Alzheimer's disease (AD).

• Journal of Microbiology and Biotechnology
• /
• 제32권9호
• /
• pp.1154-1167
• /
• 2022

In this study, we investigated the anti-amnesic effect of Korean red pine (Pinus densiflora) bark extract (KRPBE) against amyloid beta_1-42 (Aβ_1-42)-induced neurotoxicity. We found that treatment with KRPBE improved the behavioral function in Aβ-induced mice, and also boosted the antioxidant system in mice by decreasing malondialdehyde (MDA) content, increasing superoxide dismutase (SOD) activities, and reducing glutathione (GSH) levels. In addition, KRPBE improved the cholinergic system by suppressing reduced acetylcholine (ACh) content while also activating acetylcholinesterase (AChE), regulating the expression of choline acetyltransferase (ChAT), postsynaptic density protein-95 (PSD-95), and synaptophysin. KRPBE also showed an ameliorating effect on cerebral mitochondrial deficit by regulating reactive oxygen species (ROS), mitochondrial membrane potential (MMP) and ATP levels. Moreover, KRPBE modulated the expression levels of neurotoxicity indicators Aβ and phosphorylated tau (p-tau) and inflammatory cytokines TNF-α, p-IκB-α, and IL-1β. Furthermore, we found that KRPBE improved the expression levels of neuronal apoptosis-related markers BAX and BCl-2 and increased the expression levels of BDNF and p-CREB. Therefore, this study suggests that KRPBE treatment has an anti-amnestic effect by modulating cholinergic system dysfunction and neuroinflammation in Aβ_1-42-induced cognitive impairment in mice.

• 한국응용약물학회:학술대회논문집
• /
• 한국응용약물학회 2005년도 춘계학술대회
• /
• pp.53-60
• /
• 2005

Parkinson's disease (PD) is a progressive neurodegenerative disorder affecting $1\%$ of the population above the age of 65 and is characterized by a selective loss of dopaminergic neurons in the substantia nigra pars compacta. Although the underlying cause of dopaminergic cell death or the mechanism by which these cells degenerate is still not clearly understood, oxidative stress, mitochondrial dysfunction, and protein misfolding are thought to play important roles in the dopaminergic degeneration in PD. Tetrahydrobiopterin (BH4) is synthesized exclusively in the monoaminergic, including dopaminergic, cells and serves as an endogenous and obligatory cofactor for syntheses of the potential oxidative stressors dopamine and nitric oxide. In addition to its contribution toward the syntheses of these two potentially toxic molecules, BH4 itself can directly generate oxidative stress. BH4 undergoes oxidation during the hydroxylation reaction as well as nonenzymatic autooxidation to produce hydrogen peroxide and superoxide radical. We have previously suggested BH4 as an endogenous molecule responsible for the dopaminergic neurodegeneration. BH4 exerts selective toxicity to dopamine-producing cells via generation of oxidative stress, mitochondrial dysfunction, and apoptosis. BH4 also induces morphological, biochemical, and behavioral characteristics associated with PD in vivo. BH4 as well as enzyme activity and gene expression of GTP cyclohydrolase I, the rate-limiting enzyme in BH4 synthesis pathway, are readily upregulated by cellular changes such as calcium influx and by various stimuli including stress situations. This points to the possibility that cellular availability of BH4 might be increased in aberrant conditions, leading to increased extracellular BH4 subsequent degeneration. The fact that BH4 is specifically and endogenously synthesized in dopaminergic cells, Is readily upregulated, and generates oxidative stress-related cell death provides physical relevance of this molecule as an attractive candidate with which to explain the mechanism of pathogenesis of PD.

• 정신신체의학
• /
• 제7권1호
• /
• pp.10-25
• /
• 1999

2세이상의 어린이는 성적 흥분을 느낄 수 있기에 만지거나 자위행위 등의 성적인 즐거움을 찾기 시작 한다. 60년대 후반부터 70년대 초반사이 산부인과 의사 Masters와 사회사업가 Johnson은 인간의 성반응 단계를 흥분기, 고원기, 오르가슴기, 반응소실기의 4단계로 나눠 설명하였고, 여성에게는 무반응기가 없어 여러번의 오르가슴이 가능함을 밝혔다. 그들의 성치료원칙은 행동치료에 입각하여 감각초점법과 부부치료, 성교육등으로 구성되어있다. Masters와 Johnson이후 정신과 의사이자 정신분석가인 Kaplan이 1970년대 초반에 정신분석적 정신치료와 행동치료를 결합한 '새로운 성치료'를 제안했다. 그리고, 성기능 장애를 3가지 카테고리로 재분류했다. 1980년대 이후는 남성의 발기부전의 치료를 중심으로 의학적 치료방법론이 대세를 이루고 있는데, 음경 보속물, 국소주사치료, 경구약제등이 발달하였다. 최근 Sildenafil(Viagra)이 등장해 남성 발기부전 치료의 최선의 선택으로 받아들여지고 있다.